Jin Medical International Ltd. (ZJYL) P/E Ratio History
Historical price-to-earnings valuation from 2023 to 2025
Loading P/E history...
ZJYL Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Jin Medical International Ltd. (ZJYL) trades at a price-to-earnings ratio of 90.2x, with a stock price of $2.12 and trailing twelve-month earnings per share of $0.03.
The current P/E is 90% below its 5-year average of 863.2x. Over the past five years, ZJYL's P/E has ranged from a low of 218.6x to a high of 1807.1x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, ZJYL trades at a 306% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 176.0x.
The PEG ratio of 4.32 (P/E divided by 19% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, ZJYL commands a significant premium over the S&P 500 median P/E of 24.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ZJYL DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ZJYL P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $79B | 125.6 | 4.26 | -65% | |
| $2B | 6.9Lowest | 0.67Best | +817%Best | |
| $2B | 42.8 | 2.21 | +31% | |
| $98B | 21.1 | - | +31% | |
| $109B | 34.0 | 2.29 | +8% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ZJYL Historical P/E Data (2023–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Sun Mar 30 2025 00:00:00 GM | $14.05 | $0.03 | 469.9x | -46% |
| FY2024 Q4 | Mon Sep 30 2024 00:00:00 GM | $53.80 | $0.04 | 1236.8x | +43% |
| FY2024 Q2 | Sat Mar 30 2024 00:00:00 GM | $76.80 | $0.04 | 1807.1x | +109% |
| FY2023 Q4 | Sat Sep 30 2023 00:00:00 GM | $23.40 | $0.04 | 583.5x | -32% |
| FY2023 Q2 | $7.65 | $0.04 | 218.6x | -75% |
Average P/E for displayed period: 863.2x
See ZJYL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZJYL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZJYL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonZJYL — Frequently Asked Questions
Quick answers to the most common questions about buying ZJYL stock.
Is ZJYL stock overvalued or undervalued?
ZJYL trades at 90.2x P/E, below its 5-year average of 863.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does ZJYL's valuation compare to peers?
Jin Medical International Ltd. P/E of 90.2x compares to sector median of 22.2x. The premium reflects expected growth above peers.
What is ZJYL's PEG ratio?
ZJYL PEG ratio is 4.32. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2023-2025.